ARTA
ATNM icon

A.R.T. Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

A.R.T. Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,314
Closed -$26K – 1481
2017
Q4 		$26K Buy
1,314
+314
+31% +$6.32K ﹤0.01% 1307
2017
Q3 		$17K Buy
1,000
+496
+98% +$10.9K ﹤0.01% 1291
2017
Q2 		$18K Buy
+504
New +$21.1K ﹤0.01% 1343
2015
Q2 		– Sell
-1,114
Closed -$82K – 1473
2015
Q1 		$82K Buy
1,114
+550
+98% +$65.4K ﹤0.01% 1330
2014
Q4 		$99K Buy
+564
New +$107K ﹤0.01% 1305

Other funds holding ATNM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's ATNM Position: Q1 2018 in Review

A.R.T. Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q1 2018, closing a stake of 1,314 shares — an estimated $26K sold.

A.R.T. Advisors first reported a position in ATNM in Q4 2014 and held it in 5 quarters. The position peaked at $99K in Q4 2014. 36 funds tracked by Wall St. Rank hold ATNM as of Q1 2018.

  • A.R.T. Advisors reported no remaining Actinium Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 1,314 Actinium Pharmaceuticals shares in Q1 2018, an estimated $26K.
  • A.R.T. Advisors first reported a position in Actinium Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • A.R.T. Advisors's Actinium Pharmaceuticals position peaked at $99K in Q4 2014.
  • 36 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2018.

Based on A.R.T. Advisors's 13F filing for Q1 2018, filed 15 May 2018.